JESSICA ARAUZ: Open Payments
NPI 1114265642 · JERSEY CITY, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,246 in 49 payments from 11 companies in 2025. Trend: 2023 $735 · 2024 $1,453 · 2025 $1,246
Food & beverage: $1,246
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 6 | $323 |
| United Therapeutics Corporation | 10 | $250 |
| Merck Sharp & Dohme LLC | 11 | $188 |
| E.R. Squibb & Sons, L.L.C. | 4 | $142 |
| Amgen Inc. | 6 | $139 |
| BridgeBio Pharma, Inc. | 4 | $71 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $36 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $32 |
| AstraZeneca Pharmaceuticals LP | 2 | $30 |
| CVRx, Inc. | 1 | $21 |
Products named: Wegovy, Tyvaso, VERQUVO, CAMZYOS, Repatha, Attruby, Kerendia, JARDIANCE.
Industry payments across NJ — which companies pay providers there.
